Literature DB >> 16685577

Interviewer variability - quality aspects in a case-control study.

Kerstin J Blomgren1, Anders Sundström, Gunnar Steineck, Bengt-Erik Wiholm.   

Abstract

Quality assurance and quality control are important for the reliability of case-control studies. Here we describe the procedures used in a previously published study, with emphasis on interviewer variability. To evaluate risk factors for acute pancreatitis, information including previous diagnoses and medication was collected from medical records and by telephone interviews from 462 cases and 1781 controls. Quality assurance procedures included education and training of interviewers and data validity checks. Quality control included a classification test, annual test interviews, expert case validation, and database validation. We found pronounced variations between interviewers. The maximal number of interviews per day varied from 3 to 9. The adjusted average (95% CI) number of diagnoses captured per interview of cases was 4.1 (3.8-4.3) and of controls 3.5 (3.4-3.7) (excluding one deviating interviewer). For drugs, the average (95% CI) number per interview was 3.9 (3.7-4.1) for cases and 3.3 (3.2-3.4) for controls (excluding one deviating interviewer). One of the fourteen interviewers deviated significantly from the others, and more so for controls than for cases. This interviewer's data ;were excluded. Nonetheless, data concerning controls more frequently needed correction and supplementation than for cases. Erroneous coding of diagnoses and medication was also more frequent among controls. Thus, a system for quality control of coding practices is crucial. Variability in interviewers' ability to ascertain information is a possible source of bias in interview-based case-control studies when "blinding" cannot be achieved.

Entities:  

Mesh:

Year:  2006        PMID: 16685577     DOI: 10.1007/s10654-006-0017-7

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  28 in total

1.  Ensuring data quality in the pharmaceutical industry.

Authors:  C M Collins
Journal:  J AHIMA       Date:  1998-06

2.  On the differences in psychotropic drug use between the three major urban areas in Sweden.

Authors:  A Wessling; U Bergman; B Westerholm
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Obesity and treatment of diabetes with glyburide may both be risk factors for acute pancreatitis.

Authors:  Kerstin B Blomgren; Anders Sundström; Gunnar Steineck; Bengt E Wiholm
Journal:  Diabetes Care       Date:  2002-02       Impact factor: 19.112

Review 4.  Monitoring clinical trials.

Authors:  K Sharples; T R Fleming; S MacMahon; A Moore; I Reid; B Scoggins
Journal:  N Z Med J       Date:  1998-08-28

Review 5.  Quality assurance and quality control in longitudinal studies.

Authors:  C W Whitney; B K Lind; P W Wahl
Journal:  Epidemiol Rev       Date:  1998       Impact factor: 6.222

6.  Measurement and data quality in longitudinal research.

Authors:  L R Bergman
Journal:  Eur Child Adolesc Psychiatry       Date:  1996       Impact factor: 4.785

7.  Interviewer effects in a cohort study. Results from the Massachusetts Women's Health Study.

Authors:  C B Johannes; S L Crawford; J B McKinlay
Journal:  Am J Epidemiol       Date:  1997-09-01       Impact factor: 4.897

8.  Data quality in a distributed data processing system: the SHEP Pilot Study.

Authors:  A Bagniewska; D Black; K Molvig; C Fox; C Ireland; J Smith; S Hulley
Journal:  Control Clin Trials       Date:  1986-03

9.  Computer-assisted data collection in multicenter epidemiologic research. The Atherosclerosis Risk in Communities Study.

Authors:  D H Christiansen; J D Hosking; A L Dannenberg; O D Williams
Journal:  Control Clin Trials       Date:  1990-04

10.  Quality assurance and monitoring in the Hypertension Prevention Trial. Hypertension Prevention Trial Research Group.

Authors:  G J Prud'homme; P L Canner; J A Cutler
Journal:  Control Clin Trials       Date:  1989-09
View more
  3 in total

1.  Determinants of quality of interview and impact on risk estimates in a case-control study of bladder cancer.

Authors:  Cristina M Villanueva; Debra T Silverman; Núria Malats; Adonina Tardon; Reina Garcia-Closas; Consol Serra; Alfredo Carrato; Joan Fortuny; Nathaniel Rothman; Mustafa Dosemeci; Manolis Kogevinas
Journal:  Am J Epidemiol       Date:  2009-05-28       Impact factor: 4.897

2.  The ISoP Bengt-Erik Wiholm Memorial Lecture.

Authors:  I Ralph Edwards
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 3.  Comparison of pooled risk estimates for adverse effects from different observational study designs: methodological overview.

Authors:  Su Golder; Yoon K Loke; Martin Bland
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.